Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
deCODE genetics
Reykjavík, Iceland
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
01
Overview
deCODE has discovered key genetic risk factors for dozens of common diseases and has isolated 15 disease genes. Recent discoveries include a rare missense variant in FRS3 that protects against obesity, rare loss-of-function variants in HECTD2 and AKAP11 that confer risk of bipolar disorder, and a complete recombination map of the human genome.
- Therapeutic areas
- PsychiatryCardiovascularEndocrinologyOncologyNeurology
- Modalities
- Genetic testingDNA sequencingGenomic analysis
- Industry
- Molecular Diagnostics
02
Partnerships
Beyond the preview
Go deeper on deCODE genetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on deCODE genetics.